Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA® home sleep apnea test.
NORTH PHILADELPHIA (WPVI) -- Few things are as precious as a good night's sleep. People who snore, gasp, or stop breathing may fear overnight testing in a sleep lab. There's been a revolution in ...
Huxley Medical, Inc. announced the SANSA® home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...
WASHINGTON — Loud snoring doesn't just annoy your spouse. It could signal dangerous sleep apnea, yet millions go undiagnosed. A government move may help change that: Medicare is poised to allow ...
There are three main types of sleep apnea: obstructive sleep apnea (OSA), central sleep apnea (CSA) and complex sleep apnea syndrome (CSAS). OSA, the most common form, occurs when the muscles in the ...
Sleep apnea affects nearly 39 million people in the United States, with many more potentially undiagnosed due to the traditional requirement of a clinical sleep study. However, new options are ...
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...
ORLANDO, FL — Sleep-disordered breathing (SDB) identified during acute decompensated heart failure (ADHF) hospitalization, especially central sleep apnea (CSA), predicted elevated cardiac readmission ...
Audrey Stetson and John Redfield stop by Rest Up Sleep Solutions in Escanaba to learn about dental appliances that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback